 |
|
Conference report highlights new research into drug delivery to treat eye disease
November 18, 2008Group explores alternatives to surgery and intravitreous injection
Rockville, MD - Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
The report (http://www.iovs.org/cgi/content/full/49/11/4712) includes summaries from seven sessions on techniques for ocular drug delivery to the posterior segment of the eye and includes the findings of and opinions of more than 30 top ophthalmic researchers, brought together by the ARVO Foundation for Eye Research. The article in the November issue of Investigative Opthalmology & Visual Science defines the current research and the future needs for ocular drug delivery.
Diseases of the posterior segment of the eye are responsible for the majority of visual impairment and blindness cases in the United States, according to George Williams, MD. Until recently, these diseases were primarily treated with surgery, but recent developments in drug therapies have either replaced or complemented surgery.
But the challenge lies in delivering the drugs. Topical delivery such as ointments and drops are fairly ineffective, and delivery via intravitreous injection (an injection into the fluid in the behind the lens in the eye) can be hard on the patient. According to the report, "Improved drug delivery technologies that provide optimal pharmacokinetics, dose intervals and less invasive routes of administration are needed."
During the two-day event, John Heckenlively, MD, joined Jayakrishna Ambarti, MD, in a session on animal models of posterior ocular diseases. Allan Hoffman, ScD, discussed the design of polymer carriers for intracellular delivery of biomolecular drugs, such as peptides, proteins and nucleic acid drugs. His group is focused on using a family of acid-sensitive polymers to help deliver one of the latest drugs, silencing RNA (siRNA).
Another group of presenters discussed the use of nanoparticles, microbeads and microneedles. Mansoor M. Amiji, PhD, said that nanoparticles can help overcome barriers to drug delivery from the organ level to the subcellular level. Another research laboratory was investigating the effectiveness of hollow and solid microneedles that penetrate only hundreds of micrometers into the cornea or sclera to deliver drugs.
A safer alternative to direct intravitreous injections might be transscleral delivery into the vitreous using subconjunctival injections, said Michael Robinson, MD, adding that researchers needed a clear understanding of the dynamic barriers for the technique to work in treating retinal diseases. Another researcher in this area, Dayle H. Geroski, PhD, suggested that the relatively high permeability of the sclera offers great potential for transscleral drug delivery, especially for administration to the posterior part of the eye.
Other research focused on photodynamic therapy, which uses a photosensitizer agent that localizes more or less selectively to the target tissue and is activated by light, triggering chemical reactions that injure the target tissue.
Association for Research in Vision and Ophthalmology
Diseases of the posterior segment of the eye are responsible for the majority of visual impairment and blindness cases in the United States, according to George Williams, MD. Until recently, these diseases were primarily treated with surgery, but recent developments in drug therapies have either replaced or complemented surgery.
But the challenge lies in delivering the drugs. Topical delivery such as ointments and drops are fairly ineffective, and delivery via intravitreous injection (an injection into the fluid in the behind the lens in the eye) can be hard on the patient. According to the report, "Improved drug delivery technologies that provide optimal pharmacokinetics, dose intervals and less invasive routes of administration are needed."
During the two-day event, John Heckenlively, MD, joined Jayakrishna Ambarti, MD, in a session on animal models of posterior ocular diseases. Allan Hoffman, ScD, discussed the design of polymer carriers for intracellular delivery of biomolecular drugs, such as peptides, proteins and nucleic acid drugs. His group is focused on using a family of acid-sensitive polymers to help deliver one of the latest drugs, silencing RNA (siRNA).
Another group of presenters discussed the use of nanoparticles, microbeads and microneedles. Mansoor M. Amiji, PhD, said that nanoparticles can help overcome barriers to drug delivery from the organ level to the subcellular level. Another research laboratory was investigating the effectiveness of hollow and solid microneedles that penetrate only hundreds of micrometers into the cornea or sclera to deliver drugs.
A safer alternative to direct intravitreous injections might be transscleral delivery into the vitreous using subconjunctival injections, said Michael Robinson, MD, adding that researchers needed a clear understanding of the dynamic barriers for the technique to work in treating retinal diseases. Another researcher in this area, Dayle H. Geroski, PhD, suggested that the relatively high permeability of the sclera offers great potential for transscleral drug delivery, especially for administration to the posterior part of the eye.
Other research focused on photodynamic therapy, which uses a photosensitizer agent that localizes more or less selectively to the target tissue and is activated by light, triggering chemical reactions that injure the target tissue.
Association for Research in Vision and Ophthalmology
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Liver Injury Paleontology Amazon rainforest Coronary Heart Disease Uterine Fibroids Spinal Cord Memory loss Children Pancreatic Cancer Drugs Beta Cells Pheromone Fishing Robotic Surgery Brain Damage Testosterone Stomach Cancer Parasite Virtual Reality Body Image Dementia Insomnia Gravitational Wave Insulin Resistance Bullying
See More: Science News Tags
Eye Disease Current Events and Eye Disease News RSSU finds treatment that significantly slows progression of eye damage in persons with type 1 diabetes
University of Minnesota Medical School researcher Michael Mauer, M.D., has found a treatment that significantly slows the progression of eye injury in people with type 1 diabetes, a common complication caused by this disease.
'Nature' and 'nurture' variables early predictors of AMD
Like many diseases, causes for age-related macular degeneration (AMD) can be categorized as either "nature" or "nurture".
New supplement may help slow sight loss in elderly
Queen's University Belfast academics have helped develop an antioxidant supplement which may slow down sight loss in elderly people.
Omega-3 fatty acids appear to impact AMD progression
Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken.
Sight for sore eyes
In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.
Old diabetes drug teaches experts new tricks
Research from the Johns Hopkins Children's Center reveals that the drug most commonly used in type 2 diabetics who don't need insulin works on a much more basic level than once thought, treating persistently elevated blood sugar - the hallmark of type 2 diabetes - by regulating the genes that control its production.
Type of vitamin B1 could treat common cause of blindness
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Study reports success in treating a rare retinal disorder
Patients with a rare, blinding eye disease saw their vision improve after treatment with drugs to suppress their immune systems, according to researchers at the University of Michigan Kellogg Eye Center.
Study reports success in treating a rare retinal disorder
Patients with a rare, blinding eye disease saw their vision improve after treatment with drugs to suppress their immune systems.
Stem cell therapy makes cloudy corneas clear, according to Pitt researchers
Stem cells collected from human corneas restore transparency and don't trigger a rejection response when injected into eyes that are scarred and hazy, according to experiments conducted in mice by researchers at the University of Pittsburgh School of Medicine.
More Eye Disease Current Events and Eye Disease News Articles
 |
The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease (Rhee, The Wills Eye Manual) by Justis P Ehlers (Editor), Chirag P Shah (Editor), Gregory L Fenton (Editor), Eliza N Hoskins (Editor), Heather N Shelsta (Editor) Now in full color and completely updated, the Fifth Edition of this best-selling manual is a reliable quick-reference guide for all clinicians who treat eye disorders. Every disorder encountered in the office, emergency room, or hospital is covered in concise outline format: symptoms, signs, work-up, treatment, and follow-up. Also included are chapters on differential diagnosis of ocular symptoms and signs, a section on current imaging modalities in ophthalmology, and a Pharmacopoeia. This edition features over 200 full-color photographs and includes the newest drugs, procedures, and treatment protocols. New topics covered include iridodialysis/cyclodialysis, shaken baby syndrome, crystalline keratopathy, refractive surgery complications, aberrant regeneration of the third nerve, venous... |
 |
Common Eye Diseases and their Management (Common Eye Diseases and Their Management (Galloway)) by Nicholas R. Galloway (Author), Winfried M. K. Amoaku (Author), Peter H. Galloway (Author), Andrew C Browning (Author) Since the last edition was published, the teaching of Ophthalmology at primary care level has become more rather than less important. The specialty has developed more subspecialties, and the referring doctor has to have a good knowledge of these in order to make appropriate referrals. An increased emphasis on screening has made it necessary for the primary care doctor to have a basic knowledge of eye diseases. This applies particularly to glaucoma and diabetic eye disease. The management of eye conditions in the elderly is also an important and increasing primary care problem. Essential for medical students and general practitioners as well as optometrists and nurses, the book is problem-orientated and deals with the science of Ophthalmology at a basic level. This third edition... |
 |
Thyroid Eye Disease: Diagnosis And Treatment by Taylor & Francis This reference details the anatomy and physiology of the thyroid gland, the environmental and genetic factors associated with Graves' disease, and the immunological mechanisms responsible for related systemic disorders and inflammations of the eye and adjacent tissue structures. Written by more than 60 esteemed international authorities, Thyroid Eye Disease is a useful source for ophthalmologists, endocrinologists, internists, pathologists, immunologists, cosmetic surgeons, biomedical researchers, otolaryngologists, biochemists, and graduate and medical school students in these disciplines. |
 |
Thyroid Eye Disease: Diagnosis and Treatment by Jonathan J. Dutton (Editor), Barrett Haik (Editor) Univ. of North Carolina, Chapel Hill. Details the anatomy and physiology of the thyroid gland, the environmental and genetic factors associated with Graves' disease, and the immunological mechanisms responsible for related systemic disorders and inflammations of the eye and adjacent tissue structures. Includes halftone illustrations. |
 |
Posterior Eye Disease and Glaucoma A-Z by Adrian S. Bruce BScOptom PhD FAAO FVCO (Author), Justin O'Day FRACS FRACP FRCS FRANZCO FRCOphth (Author), Daniel McKay (Author), Peter G. Swann BSc(Hons) MAppSc FCOptom FAAO (Author) This title is directed primarily towards health care professionals outside of the United States. It is a handy A-Z pocket book that covers a broad range of posterior segment eye conditions and how to manage them with ocular therapeutics. It provides essential treatment protocols and down-to-earth sensible advice and lists differential diagnoses. The A-Z format gives instant access to clinical information Each condition is covered in a double page spread providing concise coverage Icons illustrate 'at a glance' diagnosis, treatment, management and referral options for each condition Superb full colour clinical photographs illustrate each condition Prestigious editorial team An indispensable clinical reference book for practitioners Encyclopaedia for... |
 |
Diseases of the Eye Chart by American 3B Scientific Diseases of the Eye Chart Diseases of the Eye ChartThis colorful anatomical chart presents a graphic representation of diseases of the human eye. The poster covers several aspects of diseases of the eye. This thickly laminated anatomical chart is printed on premium glossy (200 g) UV resistant paper and comes with 2 sided lamination (125 micron, 5.0 Mil) and metal eyelets to make the chart easy to display. It comes in a convenient poster size 50 x 67 cm (20x26’’) and can be written on and wiped off with non permanent markers. The 125 micron lamination ensures the chart does not curl up at the edges and the UV treatment ensures the chart does not get a faded yellow color over time.Measurements:50 x 67 cm Weight: 0,15 kg Product photo may not exactly match the product offered for sale.... |
 |
Anatomy Of Animals Eye Of Horse In Health And Disease by old-print Anatomy of animals eye of horse in health and disease anatomy of animals. By ben herring c1870. . selling at your price. . . Overall size of each print approx 9.5 x 12 inches (24.5 x 31cm).. all are genuine antique and not modern reproductions . |
 |
Balanceuticals Clear Eye & Sharp Ear Dietary Supplement Capsules, 500 mg, 60-Count Bottles (Pack of 2) by Balanceuticals Dietary Supplement. 100% Natural. Made under Supervision by China Academy of Traditional Chinese Medicine. Made of extracts from astragalus root, pueraria root, seashore vitex, common peony root, cimicifuge, phellodendron, licorice, cnidium, Chinese angel |
![Yoga for Eye Diseases [Swami Ramdev]](http://ecx.images-amazon.com/images/I/51RXS%2BAByYL._SL160_.jpg) |
Yoga for Eye Diseases [Swami Ramdev] |
 |
Thyroid Eye Disease: Understanding Graves' Ophthalmopathy by Trafford Publishing The only educational resource and guide for patients with Graves' Ophthalmopathy, an inflammatory eye disorder that often precedes, accompanies, or follows autoimmune thyroid disease. |
| © 2009 BrightSurf.com |